The Connected Health Market is expanding as healthcare providers, patients, insurers, and medical technology companies transition toward integrated digital ecosystems that improve patient monitoring, optimize clinical workflows, and enhance chronic disease management. Growth is supported by accelerating digital health adoption, expanding IoT infrastructure, supportive government policies, and investments in remote patient care.
The Connected Health Market size is expected to reach US$ 421.5 billion by 2031 from US$ 79.1 billion in 2024. The market is anticipated to register a CAGR of 27.2% during 2025–2031.
What is driving the market?
Rising chronic disease prevalence, aging global populations, and the shift toward value-based care are the primary growth drivers. Healthcare providers are increasingly adopting remote patient monitoring (RPM), telehealth platforms, and wearable devices to reduce hospital readmission rates and lower operational costs. Patients are actively seeking continuous health tracking, personalized care, and convenient access to virtual consultations.
The industry is moving beyond basic teleconsultations toward fully integrated, data-driven health management. Vendors are investing in AI-driven predictive analytics, interoperable EHR platforms, cellular-connected medical devices, and secure cloud storage. Data security concerns, lack of universal interoperability standards, high deployment costs, and regulatory compliance complexities remain notable constraints.
Download Sample Report@ https://www.theinsightpartners.com/sample/TIPRE00002975
Which region leads?
North America leads the market, accounting for an estimated 38%–42% share in 2025, driven by high healthcare expenditure, early adoption of advanced medical devices, favorable reimbursement policies for remote care, and a strong presence of major technology vendors.
Asia Pacific is the fastest-growing region, with a projected CAGR of 17.5%–18.8%. Growth is fueled by rapid digital infrastructure expansion, rising smartphone penetration, large patient populations, and government-backed e-health initiatives. China, India, and Japan present substantial growth opportunities as public and private investments focus on modernizing healthcare delivery systems. Europe holds an estimated 26%–30% share, supported by digital health mandates and integrated national healthcare networks.
Which segment leads?
By component/solution, Software & Platforms leads the market, representing an estimated 42%–46% of market revenue in 2025. Its position is supported by widespread integration of EHR systems, patient engagement portals, remote monitoring analytics, and cloud-based health data management. The segment is forecast to grow at a CAGR of 16.2%–17.0% through 2033.
By end user, Hospitals & Clinics leads with an estimated 45%–49% share in 2025, driven by high patient volumes and the adoption of enterprise-wide connected care solutions. Home Care & Remote Patient Monitoring is identified as a high-growth segment, with an estimated 16.8%–18.1% CAGR, propelled by consumer wearable devices and at-home chronic disease tracking.
Which companies are prominent?
The competitive landscape highlights prominent participants including Philips Healthcare, Medtronic plc, GE HealthCare, Abbott Laboratories, Omron Healthcare, Cerner Corporation (Oracle Health), Dexcom, Inc., ResMed, Boston Scientific Corporation, and Masimo Corporation.
These organizations compete across connected medical devices, remote patient monitoring platforms, clinical software, and AI analytics. Strategic differentiation relies on sensor accuracy, platform interoperability, regulatory approvals, cybersecurity compliance, and seamless EHR integration.
What is changing in 2026?
The market is shifting from standalone digital tools toward fully integrated, compliance-ready connected health ecosystems. Device manufacturers and software platforms are prioritizing end-to-end encryption, strict patient data privacy adherence, and standardized API frameworks to enable seamless data exchange across diverse clinical systems.
Care models are incorporating real-time AI analytics to alert care teams to patient deterioration before critical events occur. Reimbursement frameworks across key markets are expanding coverage for continuous remote monitoring and virtual care programs, accelerating institutional adoption.
What are the major investment opportunities?
The strongest opportunities lie in AI-powered predictive analytics, home-based remote patient monitoring solutions, cellular-enabled medical wearables, and cybersecurity infrastructure for health data. Investments in user-friendly continuous monitors (e.g., glucose, cardiac, and respiratory tracking) address high-demand chronic conditions.
Additional opportunities exist in interoperability middleware, multi-specialty telehealth platforms, and hospital-at-home technology suites. Developing markets across Asia Pacific and Latin America present attractive long-term expansion potential as wireless communication networks expand and healthcare providers digitize care delivery. Investors should prioritize platforms offering validated clinical utility, strong data security, clear reimbursement pathways, and scalable integration capabilities.
Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00002975
About The Insight Partners
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Information
- Email: sales@theinsightpartners.com
- Website: theinsightpartners.com
- Phone: +1-646-491-9876
